Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
 BACK TO LIST

European Patient Summary

Patient
Name: Valentino, Jolanda
DOB: 24-JUN-1948 (Age: 77)
Gender: female
ID: 4430-168549-9 (ECI)
Author
Dr. Ping, Hel
Patient summary Document
European Patient Summary
Report Date: 16-JUL-2025

Problem list

Condition Onset Date Status
Chronic congestive heart failure 02-Jul-2025 active
Osteoporosis 25-Aug-2024 active
Recurrent rectal polyp 14-Jun-2020 active
Polyp of colon 12-Mar-2019 active
Prediabetes 20-Mar-1988 active
Recurrent urinary tract infection 27-Apr-1961 active

Medication list

No known medications

Immunizations list

Vaccine Date
Influenza virus antigen only vaccine product 25-Aug-2024
SARS-CoV-2 mRNA vaccine 07-Mar-2021

Procedure History list

Procedure Date Reason
Postoperative care 29-Jun-2020 Overlapping malignant neoplasm of colon
Partial resection of colon 26-Jun-2020 Overlapping malignant neoplasm of colon

Allergies and Intolerances

Allergy/Intolerance Onset Date Status Type Reaction
? active ?

Care Plan

Active Planned Care / Goals Start Date Reason
Heart failure self management plan 16-Jul-2025 Chronic congestive heart failure (disorder)
  • Patient will monitor and record weight daily to detect early signs of fluid retention.
  • Patient will limit daily sodium intake to reduce fluid overload.
  • Patient will restrict daily fluid intake to prevent fluid overload.
  • Patient will recognize and promptly report symptoms such as increased shortness of breath, swelling, or rapid weight gain.
  • Patient will take prescribed heart failure medications as directed without missed doses.
Diabetes self management plan 20-Mar-1988 Prediabetes
  • Patient will demonstrate improved self-management of prediabetes through lifestyle modifications including diet, physical activity, and regular blood glucose monitoring.
Immunization Recommendation Due Date Reason
Vaccine product containing only Influenza virus antigen (medicinal product) 01-Oct-2025 Annual seasonal influenza vaccination

Vital Signs

Vital Signs 2025-07-02 2024-08-25
Body Weight 74.2 kg 74.2 kg
Body Height - 163.2 cm
Pain severity - 0-10 verbal numeric rating [Score] - Reported - 3 {score}
Body mass index (BMI) [Ratio] - 27.9 kg/m2
Diastolic Blood Pressure - 73 mm[Hg]
Systolic Blood Pressure - 120 mm[Hg]
Heart rate - 65 /min
Respiratory rate - 15 /min

Relevant diagnostic tests/laboratory data

Recent Lab Observations 16-JUL-2025 Reference Range Unit
Glucose [Mass/volume] in Blood 95.4 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 13.3 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 0.8 0.6 - 1.1 mg/dL
Calcium [Mass/volume] in Blood 8.6 8.6 - 10.4 mg/dL
Sodium [Moles/volume] in Blood 142.0 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.2 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 106.4 98 - 114 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 25.4 22 - 32 mmol/L

Device Use

Device Date (since)
Blood glucose meter (physical object) 20-Mar-1988